title: Iron lung vs mask ventilation in the treatment of acute on chronic respiratory failure in COPD patients: a multicenter study.
abstract: OBJECTIVE
  Evaluation of the effectiveness of negative-pressure ventilation (NPV) with the use of the iron lung vs noninvasive positive-pressure ventilation (NIPPV) in the treatment of COPD patients with acute on chronic respiratory failure.
  
  
  METHODS
  A retrospective case-control study.
  
  
  METHODS
  Four Italian respiratory intermediate ICUs.
  
  
  METHODS
  Of a total of 393 COPD patients admitted to the ICU in 1996, 53 pairs were treated with the iron lung (NPV group). Patients treated with NIPPV (NIPPV group) were matched according to mean (+/- SD) age (70.3 +/- 7.1 vs 70.3 +/- 6.9 years, respectively), sex, causes of acute respiratory failure (ARF), APACHE (acute physiology and chronic health evaluation) II score (22.4 +/- 5.3 vs 22.1 +/- 4.6, respectively), pH (7.26 +/- 0.05 vs 7.27 +/- 0.04, respectively), and PaCO(2) (88.1 +/- 11.5 vs 85.1 +/- 13.5 mm Hg, respectively) on admission to the ICU. The effectiveness of matching was 98.4%.
  
  
  RESULTS
  Five patients from the NPV group (9.4%) and seven patients from the NIPPV group (13.2%) needed endotracheal intubation (EI). The treatment failure rate (ie, death and/or need of EI) was 20.7% in the NPV group and 24.5% in the NIPPV group (difference was not significant). The mean duration of mechanical ventilation (29.6 +/- 28.6 vs 62.3 +/- 35.7 h, respectively) and length of hospital stay (10.4 +/- 4.3 vs 15 +/- 5.2 d, respectively) among the 35 concordant surviving pairs were significantly lower in the NPV group than in the NIPPV group (p = 0.001 and p = 0.001, respectively).
  
  
  CONCLUSIONS
  These data suggest that both ventilatory techniques are equally effective in avoiding EI and death in COPD patients with ARF. Prospective trials are needed to confirm these preliminary results.
authors.affiliation: Respiratory Intensive Care Unit, Azienda Ospedaliera di Careggi Firenze, Florence, Italy. acorrado@qubisoft.it
authors.forename: Antonio
authors.initials: A
authors.lastname: Corrado
authors.forename: Marco
authors.initials: M
authors.lastname: Confalonieri
authors.forename: Santino
authors.initials: S
authors.lastname: Marchese
authors.forename: Corrado
authors.initials: C
authors.lastname: Mollica
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Villella
authors.forename: Massimo
authors.initials: M
authors.lastname: Gorini
authors.forename: Rossana
authors.initials: R
authors.lastname: Della Porta
mesh_terms: D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal; D007902:Length of Stay; D008297:Male; D008397:Masks; D008875:Middle Aged; D011175:Positive-Pressure Respiration / Q000295:instrumentation*; D029424:Pulmonary Disease, Chronic Obstructive / Q000401:mortality / Q000628:therapy*; D012131:Respiratory Insufficiency / Q000401:mortality / Q000628:therapy*; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome; D015919:Ventilators, Negative-Pressure